Clear Harbor Asset Management’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Clear Harbor Asset Management’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-276,270	Closed	-$387K	–	288
2018 Q3	$387K	Sell	276,270 -840	-0.3%	-$1.5K	0.08%	164
2018 Q2	$482K	Sell	277,110 -6,450	-2%	-$11.2K	0.09%	145
2018 Q1	$519K	Sell	283,560 -34,900	-11%	-$73.7K	0.1%	129
2017 Q4	$710K	Buy	318,460 +15,000	+5%	+$37.3K	0.13%	114
2017 Q3	$880K	Buy	303,460 +400	+0.1%	+$1.36K	0.17%	101
2017 Q2	$1.35M	Buy	303,060 +8,000	+3%	+$33K	0.26%	80
2017 Q1	$1.38M	Buy	295,060 +72,300	+32%	+$419K	0.28%	80
2016 Q4	$1.36M	Buy	+222,760	New	+$1.16M	0.29%	78

Other funds holding SGYP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

OCM

Opti Capital Management New York $1.64B AUM 0% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Clear Harbor Asset Management's SGYP Position: Q4 2018 in Review

Clear Harbor Asset Management sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2018, closing a stake of 276,270 shares — an estimated $387K sold.

Clear Harbor Asset Management first reported a position in SGYP in Q4 2016 and held it in 8 quarters. The position peaked at $1.38M in Q1 2017. 89 funds tracked by Wall St. Rank hold SGYP as of Q4 2018.

Clear Harbor Asset Management reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q4 2018 after selling out during the quarter.
Clear Harbor Asset Management sold 276,270 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2018, an estimated $387K.
Clear Harbor Asset Management first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q4 2016 and held it in 8 quarters.
Clear Harbor Asset Management's Synergy Pharmaceuticals, Inc Common Stock position peaked at $1.38M in Q1 2017.
89 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2018.

Based on Clear Harbor Asset Management's 13F filing for Q4 2018, filed 11 Feb 2019.